These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 25857336)

  • 1. Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute.
    Miyake M; Gotoh D; Shimada K; Tatsumi Y; Nakai Y; Anai S; Torimoto K; Aoki K; Tanaka N; Konishi N; Fujimoto K
    Int J Urol; 2015 Jun; 22(6):541-7. PubMed ID: 25857336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
    Yanagisawa T; Sato S; Hayashida Y; Okada Y; Matsukawa A; Iwatani K; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
    Histopathology; 2024 Jul; 85(1):92-103. PubMed ID: 38477374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the EORTC and CUETO Models to Predict Recurrence and Progression in High-risk Non-muscle-invasive Bladder Cancer Patients.
    Pazır Y; Esmeray A; Gelmis M; Caglar U; Ozgor F; Sarılar O; Akbulut F
    Urol J; 2024 May; 21(3):169-174. PubMed ID: 38493314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.
    Simon M; Bosset PO; Rouanne M; Benhamou S; Radulescu C; Molinié V; Neuzillet Y; Paoletti X; Lebret T
    PLoS One; 2019; 14(2):e0211721. PubMed ID: 30811419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence.
    Cao J; Xu R; Zhao X; Zhong Z; Zhang L; Zhu X; Wu S; Ai K
    Sci Rep; 2016 Jul; 6():29466. PubMed ID: 27385379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?
    Finocchiaro A; Paciotti M; Contieri R; Fasulo V; Saita A; Lughezzani G; Buffi NM; Lazzeri M; Hurle R; Casale P
    BJU Int; 2024 Aug; 134(2):195-197. PubMed ID: 38774951
    [No Abstract]   [Full Text] [Related]  

  • 7. Can the use of antithrombotic drugs be a predictive factor in the early diagnosis of bladder cancer?: A single-center analysis.
    Ekici M; Demir E; Aydin C; Çağlayan MS; Özgür BC; Baykam MM
    Medicine (Baltimore); 2024 May; 103(20):e38228. PubMed ID: 38758868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up.
    Yu YD; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
    Front Oncol; 2021; 11():683190. PubMed ID: 34136407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer: Main Conclusions and Recommendations.
    van der Kwast TH; Bubendorf L; Cheng L
    Eur Urol; 2024 May; 85(5):411-413. PubMed ID: 38413300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer.
    Lopez-Beltran A; Raspollini MR; Hansel D; Compérat E; Williamson SR; Liedberg F; Iczkowski KA; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e24-e31. PubMed ID: 37737692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITM2A inhibits the progression of bladder cancer by downregulating the phosphorylation of STAT3.
    Jiang J; Xu J; Ou L; Yin C; Wang Y; Shi B
    Am J Cancer Res; 2024; 14(5):2202-2215. PubMed ID: 38859860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
    Li Y; Chen T; Fu B; Luo Y; Chen L
    Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer.
    Miyake M; Nishimura N; Ohnishi S; Oda Y; Owari T; Ohnishi K; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Fujii T; Tanaka N; Fujimoto K
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Urothelial Carcinoma and Normal Bladder Tissues by Means of Fiber-Based ATR IR Spectroscopy.
    Bandzevičiūtė R; Platkevičius G; Čeponkus J; Želvys A; Čekauskas A; Šablinskas V
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.
    Bhindi B; Kool R; Kulkarni GS; Siemens DR; Aprikian AG; Breau RH; Brimo F; Fairey A; French C; Hanna N; Izawa JI; Lacombe L; McPherson V; Rendon RA; Shayegan B; So AI; Zlotta AR; Black PC; Kassouf W
    Can Urol Assoc J; 2021 Aug; 15(8):E424-E460. PubMed ID: 33938798
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.
    Miyake M; Iida K; Nishimura N; Miyamoto T; Fujimoto K; Tomida R; Matsumoto K; Numakura K; Inokuchi J; Morizane S; Yoneyama T; Matsumura Y; Abe T; Inoue M; Yamada T; Terada N; Hirao S; Uemura M; Matsushita Y; Taoka R; Kobayashi T; Kojima T; Matsui Y; Kitamura H; Nishiyama H;
    BMC Cancer; 2021 Mar; 21(1):266. PubMed ID: 33706705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
    Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K
    Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
    Miyake M; Nishimura N; Nakai Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder.
    Itami Y; Miyake M; Ohnishi S; Tatsumi Y; Gotoh D; Hori S; Morizawa Y; Iida K; Ohnishi K; Nakai Y; Inoue T; Anai S; Tanaka N; Fujii T; Shimada K; Furuya H; Khadka VS; Deng Y; Fujimoto K
    Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31968685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future 'MRI-PDD Fusion TURBT'.
    Miyake M; Maesaka F; Marugami N; Miyamoto T; Nakai Y; Ohnishi S; Gotoh D; Owari T; Hori S; Morizawa Y; Itami Y; Inoue T; Anai S; Torimoto K; Fujii T; Shimada K; Tanaka N; Fujimoto K
    Diagnostics (Basel); 2019 Sep; 9(3):. PubMed ID: 31487881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.